{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T02:26:06Z","timestamp":1767666366499,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.imbio.2011.11.009","type":"journal-article","created":{"date-parts":[[2011,12,7]],"date-time":"2011-12-07T18:42:19Z","timestamp":1323283339000},"page":"698-703","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Eculizumab treatment modifies the immune profile of PNH patients"],"prefix":"10.1016","volume":"217","author":[{"given":"Fiorella","family":"Alfinito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppina","family":"Ruggiero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michela","family":"Sica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annapoorani","family":"Udhayachandran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Rubino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta Della","family":"Pepa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna T.","family":"Palatucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariangela","family":"Annunziatella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosario","family":"Notaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio M.","family":"Risitano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Terrazzano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2011.11.009_bib0005","first-page":"1326","article-title":"Blood cell flow cytometry in paroxysmal nocturnal hemoglobinuria: a tool for measuring the extent of the PNH clone","volume":"10","author":"Alfinito","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.imbio.2011.11.009_bib0010","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-2141.2009.07921.x","article-title":"Immune dysregulation and dyserythropoiesis in the myelodysplastic syndromes","volume":"148","author":"Alfinito","year":"2010","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.imbio.2011.11.009_bib0015","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.blre.2007.10.002","article-title":"Advances in the diagnosis and therapy of paroxysmal nocturnal hemoglobinuria","volume":"22","author":"Brodsky","year":"2008","journal-title":"Blood Rev."},{"key":"10.1016\/j.imbio.2011.11.009_bib0020","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.molimm.2004.03.017","article-title":"The complement system in B cell regulation","volume":"41","author":"Carroll","year":"2004","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imbio.2011.11.009_bib0025","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/ni1113","article-title":"The complement system in regulation of adaptive immunity","volume":"5","author":"Carroll","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imbio.2011.11.009_bib0030","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0005-2736(02)00686-7","article-title":"Critical review of acylation-stimulating protein physiology in humans and rodents","volume":"1609","author":"Cianflone","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.imbio.2011.11.009_bib0035","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1182\/blood-2005-03-1337","article-title":"Immunoselection by natural killer cells of PIG-A mutant cells missing stress-inducible ULBP","volume":"107","author":"Hanaoka","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2011.11.009_bib0040","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1084\/jem.20041967","article-title":"Decay-accelerating factor modulates induction of T cell immunity","volume":"201","author":"Heeger","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2011.11.009_bib0045","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa061648","article-title":"The Complement inhibitor Eculizumab in paroxysmal nocturnal hemoglobinuria","volume":"355","author":"Hillmen","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imbio.2011.11.009_bib0050","doi-asserted-by":"crossref","first-page":"716","DOI":"10.4049\/jimmunol.165.2.716","article-title":"Cytokines and cell surface molecules independently induce CXCR4 expression on CD4+ CCR7+ human memory T cells","volume":"165","author":"Jourdan","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2011.11.009_bib0055","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1182\/blood.V96.7.2613","article-title":"Abnormal T cell repertoire is consistent with immune process underlying the pathogenesis of paroxysmal nocturnal hemoglobinuria","volume":"96","author":"Karadimitris","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2011.11.009_bib0060","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/sj.leu.2404080","article-title":"Cytolytic function and survival of Natural Killer cells are severely altered in Myelodysplastic Syndromes","volume":"20","author":"Kiladjian","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.imbio.2011.11.009_bib0065","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/leu.2008.333","article-title":"Kinetics, function and bone marrow trafficking of CD4+ CD25+ Foxp3+ regulatory T cells in Myelodysplastic Syndromes","volume":"23","author":"Kotsianidis","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.imbio.2011.11.009_bib0070","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00005-009-0047-4","article-title":"Complement: coming full circe","volume":"57","author":"Le Friec","year":"2009","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"10.1016\/j.imbio.2011.11.009_bib0075","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1084\/jem.20040863","article-title":"The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo","volume":"201","author":"Liu","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2011.11.009_bib0080","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.it.2005.12.008","article-title":"Holding T cells in check\u2014a new role for complement regulators?","volume":"27","author":"Longhi","year":"2006","journal-title":"Trends Immunol."},{"key":"10.1016\/j.imbio.2011.11.009_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0092-8674(00)81850-4","article-title":"Somatic mutations in Paroxysmal Nocturnal Hemoglobinuria: a blessing in disguise?","volume":"88","author":"Luzzatto","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.imbio.2011.11.009_bib0090","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.gde.2006.04.015","article-title":"Paroxysmal nocturnal hemoglobinuria: an acquired X-linked genetic disease with somatic-cell mosaicism","volume":"16","author":"Luzzatto","year":"2006","journal-title":"Curr. Opin. Gen. Dev."},{"key":"10.1016\/j.imbio.2011.11.009_bib0095","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3324\/haematol.2009.017848","article-title":"Paroxysmal nocturnal hemoglobinuria and Eculizumab","volume":"95","author":"Luzzatto","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.imbio.2011.11.009_bib0100","doi-asserted-by":"crossref","first-page":"6510","DOI":"10.4049\/jimmunol.162.11.6510","article-title":"C5a directs the in vitro migration of human memory and naive tonsillar B lymphocytes: implication for B cell trafficking in secondary lymphoid tissues","volume":"162","author":"Ottonello","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2011.11.009_bib0105","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1182\/blood-2005-04-1717","article-title":"Diagnosis and management of paroxysmal nocturnal hemoglobinuria","volume":"106","author":"Parker","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2011.11.009_bib0110","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/MOH.0b013e328302f43a","article-title":"Peripheral blood stem cell mobilization: new regimens, new cells, where do we stand","volume":"15","author":"Pelus","year":"2008","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.imbio.2011.11.009_bib0115","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1182\/blood-2002-10-3233","article-title":"Functional receptor for C3a anaphylatoxin is expressed by normal hematopoietic stem\/progenitor cells, and C3a enhances their homing\/related responses to SDF-1","volume":"101","author":"Reca","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2011.11.009_bib0120","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1182\/blood.V92.5.1799","article-title":"Lymphocyte subset analysis and glycosylphosphatidylinositol phenotype in patients with paroxysmal nocturnal hemoglobinuria","volume":"92","author":"Richards","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2011.11.009_bib0125","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imbio.2011.11.009_bib0130","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-065X.2007.00556.x","article-title":"Complement receptors CD21 and CD35 in humoral immunity","volume":"219","author":"Roozendaal","year":"2007","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.imbio.2011.11.009_bib0135","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2141.2008.07183.x","article-title":"Eculizumab a terminal complement inhibitor, improves anaemia in patients with paroxysmal nocturnal Hemoglobinuria","volume":"142","author":"Schubert","year":"2008","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.imbio.2011.11.009_bib0140","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1182\/blood.V76.6.1181.1181","article-title":"The PIG-anchoring defect in NK lymphocytes of PNH patients","volume":"76","author":"Schubert","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2011.11.009_bib0145","first-page":"69","article-title":"Interferon downregulates CXCR4 (fusin) gene expression in peripheral blood mononuclear cells","volume":"1","author":"Shirazi","year":"1998","journal-title":"J. Hum. Virol."},{"key":"10.1016\/j.imbio.2011.11.009_bib0150","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1189\/jlb.0105026","article-title":"T cells from Paroxysmal Nocturnal Hemoglobinuria (PNH) patients show an altered CD40-dependent pathway","volume":"78","author":"Terrazzano","year":"2005","journal-title":"J. Leukoc. Biol."}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298511002592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298511002592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:32:27Z","timestamp":1759249947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298511002592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0171298511002592"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2011.11.009","relation":{},"ISSN":["0171-2985"],"issn-type":[{"type":"print","value":"0171-2985"}],"subject":[],"published":{"date-parts":[[2012,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eculizumab treatment modifies the immune profile of PNH patients","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2011.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}